In the present study, we found that IGF2BP2 is highly expressed in pancreatic cancer, and upregulation of IGF2BP2 is associated with poor prognosis of pancreatic cancer patients. This evidence concerns the gene IGF2BP2 and familial pancreatic carcinoma.